Bendamustine for treatment of chronic lymphocytic leukemia

By Chang Julie Elizabeth   Kahl Brad Steven  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1495-1505

Informa Healthcare

Access to resources Recommend Favorite

Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 128-135

John Wiley & Sons Inc

Access to resources Recommend Favorite

Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens

By Thompson Philip A.   O'Brien Susan M.   Wierda William G.   Ferrajoli Alessandra   Stingo Francesco   Smith Susan C.   Burger Jan A.   Estrov Zeev   Jain Nitin   Kantarjian Hagop M.   Keating Michael J.  

Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. : 3612-3621

Blackwell Publishing

Access to resources Recommend Favorite

New treatment options for chronic lymphocytic leukemia

By Delgado Julio   Baumann Tycho   Santacruz Rodrigo   Montserrat Emili  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 823-832

Informa Healthcare

Access to resources Recommend Favorite

Novel Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

By  

Current Cancer Drug Targets, Vol. 8, Iss. 2, 2008-03 ,pp. : 156-171

Bentham Science Publishers

Access to resources Recommend Favorite